BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/6/2018 1:33:44 AM | Browse: 1048 | Download: 1806
 |
Received |
|
2018-05-05 08:29 |
|
Peer-Review Started |
|
2018-05-05 08:53 |
|
To Make the First Decision |
|
2018-05-17 02:47 |
|
Return for Revision |
|
2018-05-21 07:04 |
|
Revised |
|
2018-06-05 15:14 |
|
Second Decision |
|
2018-06-27 09:50 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2018-06-27 17:23 |
|
Articles in Press |
|
2018-06-27 17:23 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2018-08-31 09:12 |
|
Publish the Manuscript Online |
|
2018-09-06 01:33 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
From bench to bedside: fecal calprotectin in inflammatory bowel diseases clinical setting
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Maria Gloria Mumolo, Lorenzo Bertani, Linda Ceccarelli, Gabriella Laino, Giorgia Di Fluri, Eleonora Albano, Gherardo Tapete and Francesco Costa |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Francesco Costa, MD, PhD, Chief Doctor, Department of General Surgery and Gastroenterology, Azienda Ospedaliero Universitaria Pisana, Gastroenterology Unit, via Paradisa 2, Pisa 56124, Italy. fcosta@int.med.unipi.it |
| Key Words |
Fecal calprotectin; Inflammatory bowel diseases; Crohn’s disease; Ulcerative colitis; Irritable bowel syndrome |
| Core Tip |
This manuscript is a review of current literature on clinical use of fecal calprotectin in distinguishing irritable bowel syndrome from inflammatory bowel diseases and in the long-term management of inflammatory bowel disease patients, which includes monitoring of disease activity, response to therapy, disease relapse and post-operative recurrence. Concerns about the optimal cut-off in different settings have also been discussed. |
| Publish Date |
2018-09-06 01:33 |
| Citation |
Mumolo MG, Bertani L, Ceccarelli L, Laino G, Di Fluri G, Albano E, Tapete G, Costa F. From bench to bedside: fecal calprotectin in inflammatory bowel diseases clinical setting. World J Gastroenterol 2018; 24(33): 3681-3694 |
| URL |
http://www.wjgnet.com/1007-9327/full/v24/i33/3681.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v24.i33.3681 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
